Apo E phenotype and changes in serum lipids in adult patients during growth hormone replacement.
AffiliationDepartment of Endocrinology, Ninewells Hospital, Dundee, UK.
MetadataShow full item record
AbstractOBJECTIVE: To determine whether apo E phenotype influences changes in lipid profiles induced by growth hormone replacement in growth hormone (GH)-deficient adults. DESIGNS: Patients were treated for 6 months with recombinant human GH (hGH), given in a dose of 0.125 U/kg per week for 4 weeks followed by 0.25 U/kg per week thereafter. The effects on serum lipids and the influence of apo E phenotype were examined. METHODS: Thirty patients (aged 35.1+/-11.8 years: mean +/- S.D.) with adult growth hormone deficiency with included in the study. Fasting serum samples were analysed for apo E phenotype total cholesterol, high-density lipoprotein (HDL)-cholesterol, triglycerides, lipoprotein (a) (Lp(a)) and IGF-I. Low-density lipoprotein (LDL)-cholesterol was calculated using the Friedwald formula. RESULTS: Six months of replacement treatment with hGH resulted in a reduction in HDL-cholesterol from 0.90+/-0.10 to 0.68+/-0.08 mmol/l (P<0.01), and a small, non-significant reduction in total cholesterol from 6.14+/-0.40 to 5.99+/-0.35 mmol/l (P = 0.06). There was no significant change in the other lipid parameters. The decrease in HDL-cholesterol concentration was greater in patients carrying the apo E2 allele (0.40+/-0.07 mmol/l, P<0.05) than in patients homozygous for the apo E3 allele (0.23+/-0.04 mmol/l) and patients carrying the apo E4 allele (0.15+/-0.36 mmol/l). Patients with the apo E4 allele had lower baseline cholesterol concentrations than patients lacking the apo E4 allele, and this persisted after treatment with hGH (P<0.05). CONCLUSIONS: Apo E phenotype may be a determining factor in the response of HDL-cholesterol to hGH in GH-deficient adults.
CitationApo E phenotype and changes in serum lipids in adult patients during growth hormone replacement. 1999, 140 (2):174-9 Eur. J. Endocrinol.
JournalEuropean Journal of Endocrinology
- Apolipoprotein E gene polymorphism alters lipids before pancreas transplantation.
- Authors: Balakrishnan S, Colling C, Burkman T, Erickson J, Lyden E, Maheshwari H, Mack-Shipman L, Lane J, Larsen J
- Issue date: 2002 Oct 15
- HDL-cholesterol reductions associated with adult growth hormone replacement.
- Authors: Leese GP, Wallymahmed M, VanHeyningen C, Tames F, Wieringa G, MacFarlane IA
- Issue date: 1998 Nov
- Reciprocal effects of apolipoprotein E alleles (epsilon 2 and epsilon 4) on plasma lipid levels in normolipidemic subjects.
- Authors: Eto M, Watanabe K, Ishii K
- Issue date: 1986 Jun
- Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels.
- Authors: Saidi S, Slamia LB, Ammou SB, Mahjoub T, Almawi WY
- Issue date: 2007 Jul-Aug
- The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapy.
- Authors: O'Neal DN, Hew FL, Best JD, Alford F
- Issue date: 1999 Jun